ATE334136T1 - Verfahren zur herstellung von azithromycin - Google Patents

Verfahren zur herstellung von azithromycin

Info

Publication number
ATE334136T1
ATE334136T1 AT00943902T AT00943902T ATE334136T1 AT E334136 T1 ATE334136 T1 AT E334136T1 AT 00943902 T AT00943902 T AT 00943902T AT 00943902 T AT00943902 T AT 00943902T AT E334136 T1 ATE334136 T1 AT E334136T1
Authority
AT
Austria
Prior art keywords
azithromycin
producing
producing azithromycin
monohydrate
stable
Prior art date
Application number
AT00943902T
Other languages
English (en)
Inventor
Victor Centellas
Rafael Garcia
Marta Poch
Jose Diago
Johannes Ludescher
Immaculada Bosch
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9915216.7A external-priority patent/GB9915216D0/en
Priority claimed from GBGB9915218.3A external-priority patent/GB9915218D0/en
Priority claimed from GBGB9930059.2A external-priority patent/GB9930059D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Application granted granted Critical
Publication of ATE334136T1 publication Critical patent/ATE334136T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT00943902T 1999-06-29 2000-06-27 Verfahren zur herstellung von azithromycin ATE334136T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9915216.7A GB9915216D0 (en) 1999-06-29 1999-06-29 Organic compounds
GBGB9915218.3A GB9915218D0 (en) 1999-06-29 1999-06-29 Organic compounds
GBGB9930059.2A GB9930059D0 (en) 1999-12-20 1999-12-20 Organic compounds

Publications (1)

Publication Number Publication Date
ATE334136T1 true ATE334136T1 (de) 2006-08-15

Family

ID=27269768

Family Applications (2)

Application Number Title Priority Date Filing Date
AT00943902T ATE334136T1 (de) 1999-06-29 2000-06-27 Verfahren zur herstellung von azithromycin
AT06117687T ATE469910T1 (de) 1999-06-29 2000-06-27 Azithromycinmonohydrat

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT06117687T ATE469910T1 (de) 1999-06-29 2000-06-27 Azithromycinmonohydrat

Country Status (10)

Country Link
US (1) US6703372B1 (de)
EP (2) EP1712556B1 (de)
JP (2) JP4703924B2 (de)
KR (1) KR100700475B1 (de)
AT (2) ATE334136T1 (de)
AU (1) AU5820400A (de)
DE (3) DE60044515D1 (de)
ES (2) ES2267549T3 (de)
HR (1) HRP20010956B1 (de)
WO (1) WO2001000640A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020231A2 (en) * 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
CA2245398C (en) 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
DE60026718T2 (de) 2000-07-25 2006-11-16 Laboratorio Silanes, S.A. De C.V. Einstufiges verfahren zur herstellung von 7,16-deoxy-2-aza-10-o-cladinosil-12-o-desosaminil-4,5-dihydroxi-6-ethyl-3,5,9,11,13,15-hexamethylbicycle(11.2.11)hexadeca-1(2)-en-8-ona undeine neue form von 9-desoxo-9a-methyl-9a-aza-9a-homoerythromycin a
ES2172417B1 (es) * 2000-07-31 2003-09-16 Sint Quimica Sa Nueva forma mejorada de azitromicina monohidrato de menor higroscopicidad, procedimiento de preparacion y composiciones farmaceuticas que la comprenden.
JP2004519430A (ja) 2000-11-27 2004-07-02 バイオケミ・エセ・ア マクロライドの溶媒和物
HRP20010301A2 (en) * 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
HUP0400446A2 (hu) 2001-05-22 2004-09-28 Pfizer Products Inc. Azitromicin kristályformái
US6861413B2 (en) 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
EP1671978A1 (de) * 2001-05-22 2006-06-21 Pfizer Products Inc. Neue Kristallforme von Azithromycin
IL161259A0 (en) * 2001-12-21 2004-09-27 Pfizer Prod Inc Methods for wet granulating azithromycin
JPWO2003072589A1 (ja) * 2002-02-26 2005-06-16 明治製菓株式会社 新規15員環アザライド及び新規16員環ジアザライド誘導体とその製造法
CN1276919C (zh) * 2002-04-03 2006-09-27 韩美药品株式会社 阿奇霉素的制备方法及其中使用的结晶9-脱氧-9a-氮杂-9a-同型红霉素A水合物
ITMI20021209A1 (it) * 2002-06-04 2003-12-04 Chemi Spa Processo di preparazione di azitromicina ad elevata purezza
GB0214277D0 (en) * 2002-06-20 2002-07-31 Biochemie Gmbh Organic compounds
US6855813B2 (en) 2002-07-19 2005-02-15 Alembic Limited Process for the preparation of azithromycin monohydrate
HRP20020614A2 (en) * 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
GB0224197D0 (en) * 2002-10-17 2002-11-27 Biochemie Gmbh Organic compounds
US20050013835A1 (en) * 2003-07-15 2005-01-20 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
WO2005009447A1 (en) * 2003-07-24 2005-02-03 Pliva - Research And Development Ltd. Single dose fast dissolving azithromycin
US20060189800A1 (en) * 2003-07-24 2006-08-24 Mitsuru Ohkubo Indolopyrrolocabazole derivative and antitumor agent
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7683162B2 (en) 2004-08-30 2010-03-23 Taro Pharmaceutical Industries Limited Process of preparing a crystalline azithromycin monohydrate
EP1827449A4 (de) * 2004-11-17 2008-01-23 Smithkline Beecham Corp Verwendung von neuen antibakteriellen verbindungen
CN101177441B (zh) * 2007-12-05 2012-05-23 浙江耐司康药业有限公司 一种稳定的阿奇霉素一水合物结晶的制备方法
CN101445532B (zh) * 2008-12-30 2011-09-21 广东东阳光药业有限公司 阿奇霉素一水合物结晶的制备方法
JP2012520268A (ja) 2009-03-13 2012-09-06 ダ・ボルテラ グラム陰性細菌の除去のための組成物及び方法
CN102417531B (zh) * 2011-12-20 2014-06-11 浙江国邦药业有限公司 一种阿奇霉素一水合物的制备方法
CN105030704B (zh) * 2015-06-29 2018-09-07 石药集团欧意药业有限公司 阿奇霉素片剂及其制备方法
CN110684056B (zh) * 2018-07-05 2021-07-13 青岛农业大学 一种阿奇霉素中间体的化学合成方法
CN114516895A (zh) * 2020-11-19 2022-05-20 江苏威奇达药业有限公司 一种阿奇霉素胺结晶方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA835204B (en) * 1982-07-19 1985-02-27 Pfizer N-methyl 11-aza-10-deoxo-10-dihydroerythromycin a,intermediates therefor and processes for their preparation
RO107257B1 (ro) 1987-07-09 1993-10-30 Pfizer Procedeu de obtinere a unui dihidrat de azitromicina, cristalin
ES2122905B1 (es) * 1996-07-11 1999-11-16 Astur Pharma Sa Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato).
GB9705323D0 (en) * 1997-03-14 1997-04-30 Biochemie Sa Organic compounds
PT994889E (pt) * 1997-07-08 2004-10-29 Biochemie Sa Solvatos de oxima de eritromicina a
PT102130A (pt) 1998-03-13 1999-09-30 Hovione Sociedade Quimica S A Processo de preparacao de dihidrato de azitromicina
CA2245398C (en) 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
GB9824580D0 (en) * 1998-11-10 1999-01-06 Biochemie Sa Organic compounds

Also Published As

Publication number Publication date
HRP20010956B1 (hr) 2010-09-30
ATE469910T1 (de) 2010-06-15
HRP20010956A2 (en) 2003-08-31
US6703372B1 (en) 2004-03-09
ES2346782T3 (es) 2010-10-20
ES2267549T3 (es) 2007-03-16
EP1712556B1 (de) 2010-06-02
WO2001000640A1 (en) 2001-01-04
JP2011126894A (ja) 2011-06-30
DE60044515D1 (de) 2010-07-15
EP1189915B1 (de) 2006-07-26
EP1189915A1 (de) 2002-03-27
DE60029589T2 (de) 2007-07-19
JP2003503417A (ja) 2003-01-28
JP4703924B2 (ja) 2011-06-15
EP1712556A1 (de) 2006-10-18
DE60029589D1 (de) 2006-09-07
KR20020016862A (ko) 2002-03-06
KR100700475B1 (ko) 2007-03-28
DE20023815U1 (de) 2006-06-08
AU5820400A (en) 2001-01-31

Similar Documents

Publication Publication Date Title
ATE334136T1 (de) Verfahren zur herstellung von azithromycin
ATE386736T1 (de) Verfahren zur herstellung von benzimidazol-2-yl - chinolinonderivaten
DE69801489D1 (de) Verfahren zur herstellung von 1,1,1,3,3-pentafluorpropan
DE60009578D1 (de) Vorrichtung zur Herstellung von Kontaktkörpern
ATE259704T1 (de) Verfahren zur herstellung von formteilen
ATE309257T1 (de) Verfahren zur herstellung von amin-platin- komplexen
DE69941954D1 (de) Oxetanderivate, oxetancopolymer, und verfahren zur herstellung von oxetanderivaten
ATE374463T1 (de) Verfahren zur herstellung von oxazolidinonen
DE60011525D1 (de) Verfahren zur herstellung von cycloalkanonen
ATE331804T1 (de) Verfahren zur herstellung von ansamitocin
DE69927475D1 (de) Verfahren zur herstellung gesinterter körper
ATE506351T1 (de) Verfahren zur herstellung von 10,11-dihydro-10- oxo-5h-dibenzoäb,füazepin-5-carboxamid
DE50006772D1 (de) Verfahren zur herstellung von oxindolen
ATE516267T1 (de) Vefahren zur herstellung von lactamen
DE69510087D1 (de) Verfahren zur herstellung von 5-chlor-2,3-dihydro-1h-inden-1-on
ATE292602T1 (de) Verfahren zur herstellung von wasserstoffperoxid
ATE307817T1 (de) Verfahren zur herstellung von cefpodoxim-proxetil diastereoisomeren
DE69919014D1 (de) Verfahren zur herstellung von alpha, alpha-verzweigten carbonsäuren
ATE374757T1 (de) Verfahren zur herstellung von (1,4,5)- oxadiazepinderivaten
DE60002529D1 (de) Verfahren zur herstellung von wasserstoffperoxid
ATE260230T1 (de) Verfahren zur herstellung von polyolen
DE69936449D1 (de) Verfahren zur herstellung von 1,3-disubstituierten-4-oxocyclischen harnstoffen
DE69908374D1 (de) Verfahren zur herstellung von 3,5-difluoroanilin
ATE321749T1 (de) Verfahren zur herstellung aliphatischer fluoroformiate
DE59803655D1 (de) Verfahren zur herstellung von aliphatischen alpha, omega-aminonitrilen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties